Government: Page 70
-
Medicaid insurers at heart of Nevada public option plan
The state will bid out the business to private insurance carriers instead of doing the work in-house. Medicaid managed care organizations Centene, UnitedHealthcare and Anthem will be required to submit a bid.
By Samantha Liss • June 2, 2021 -
Retrieved from National Cancer Institute on September 27, 2019
In first, FDA approves KRAS-blocking cancer drug from Amgen
Lumakras is the first drug proven effective in targeting the KRAS gene, which is often mutated in lung, colon and pancreatic cancers. Amgen will charge $17,900 per month for Lumakras at list price, which doesn't account for rebates or discounts that may be offered to insurers.
By Ned Pagliarulo • June 1, 2021 -
Family healthcare costs decreased last year for first time in Milliman report's 16-year history
However, the trend is not expected to continue into 2021. Costs are predicted to jump nearly 9% to $28,256 next year for a family of four.
By Samantha Liss • May 28, 2021 -
Ransomware, other cyber threats mount as medtech industry tries to adapt
"Everything is hackable," said Kevin Fu, the FDA's medical device cybersecurity chief, who noted that ransomware in particular can render a device useless.
By Greg Slabodkin • May 27, 2021 -
Lawmakers revive push for public option with call for feedback
The latest move signals Democrats are serious about an effort to pass legislation enacting the policy, seen as a more moderate alternative to "Medicare for All."
By Samantha Liss • May 27, 2021 -
HHS commits $4.8B to COVID-19 testing for the uninsured
The American Clinical Laboratory Association, whose members include LabCorp and Quest Diagnostics, had urged the Biden administration in February to make more money available.
By Susan Kelly • May 26, 2021 -
Senate confirms Chiquita Brooks-LaSure as head of CMS
Industry groups cheered her confirmation, saying Brooks-LaSure's policy know-how and experience managing insurance programs should help increase equitable access to affordable care in the U.S.
By Rebecca Pifer Parduhn • May 25, 2021 -
Anthem wrongly received $3.4M in MA overpayments, OIG says
The insurer is the latest to face allegations of receiving Medicare Advantage overpayments tied to patients who were inaccurately identified as part of a high-risk group.
By Samantha Liss • May 25, 2021 -
Moderna, with new results, set to seek vaccine clearance for young teens
The biotech's shot was strongly protective against COVID-19 in a study of 12- to 17-year-olds, a finding that could soon make it the second vaccine available for adolescents in the U.S.
By Ben Fidler • May 25, 2021 -
Deep Dive
Medtronic HeartWare system hit with slew of Class I recalls, device reports since 2012 PMA
The pump has a higher rate of malfunction reports than rivals, according to an ECRI analysis of the FDA's MAUDE database. But it's hard to draw conclusions from a disparate system of safety reporting.
By Ricky Zipp • May 24, 2021 -
[Photograph]. Retrieved from Regional Health Command Atlantic.
More than 1 in 4 Medicare beneficiaries used telehealth between summer and fall last year
A Kaiser Family Foundation report also found a majority of beneficiaries using virtual care accessed it over the phone, hinting at continued demand for audio-only telehealth beyond the COVID-19 public health emergency.
By Rebecca Pifer Parduhn • May 20, 2021 -
US panel trims colorectal cancer screening age, broadening payer mandate
The action means private insurers have to cover the screening of adults aged 45 to 49 years under the Affordable Care Act.
By Nick Paul Taylor • May 19, 2021 -
Eli Lilly fires back against HHS order to repay providers for violating 340B
As California's Attorney General, HHS chief Xavier Becerra led a group of states pushing the agency to force drugmakers to comply with the controversial drug discount program late last year.
By Hailey Mensik , Rebecca Pifer Parduhn • Updated May 21, 2021 -
HHS asks Supreme Court to keep site-neutral payments in place
Hospitals and HHS have been wrangling about the issue since the federal agency moved to cut payments to hospital-owned outpatient sites in 2019.
By Ron Shinkman • May 17, 2021 -
CMS again delays breakthrough device payment rule in nod to skeptics
Medtech manufacturers pushed for the MCIT rule, but high-profile detractors like payer lobby America's Health Insurance Plans and doctor groups drove CMS to delay implementation, citing potential risks to Medicare beneficiaries.
By Nick Paul Taylor • May 17, 2021 -
Despite CMS rule, few hospitals post prices in a coherent fashion, study says
Among 25 common items and procedures posted by the 100 largest hospitals, far fewer than 20% of facilities had decipherable pricing for any single item, according to the research in JAMA Network Open.
By Ron Shinkman • May 14, 2021 -
Missouri Medicaid expansion hits snag, headed to court
Medicaid expansion in Missouri will now be decided by the courts as its legislature refused to allocate funds after voters approved expansion last year.
By Samantha Liss • Updated May 21, 2021 -
EU plans to impose additional regulations on medtech AI products, other 'high risk' systems
The proposed legal framework, which addresses potential artificial intelligence risks, seeks to regulate the technology and issue fines for noncompliance that could total billions of dollars, positioning Europe for a "leading" AI role globally.
By Nick Paul Taylor • May 13, 2021 -
Report calls for broader scope of practice for nurses, better support for equity, mental health
Demand for nurses will only grow post-pandemic, as will the rigors of the job, according to the paper published Tuesday from the National Academy of Medicine and Robert Wood Johnson Foundation.
By Hailey Mensik • May 12, 2021 -
CDC panel endorses Pfizer vaccine for 12- to 15-year-olds
The vote, which the CDC officially adopted hours after, gives a clear green light for states to begin vaccinating younger adolescents with the shot.
By Ned Pagliarulo • Updated May 13, 2021 -
FDA authorizes Pfizer's coronavirus vaccine for younger teens
The emergency clearance greatly expands the pool of people who can be vaccinated in the U.S. just as some states begin to report waning demand.
By Ned Pagliarulo • May 11, 2021 -
Billions of dollars remain in the provider relief fund. Hospital execs are left in the lurch waiting for relief.
"My greatest frustration is just the unknown," one Illinois hospital official said. "There seems to be a vacuum of information out there about how much is there, when would you expect it, how do you apply for it."
By Samantha Liss • May 11, 2021 -
TAVR readmission rates vary widely between hospitals for unknown reasons
Length of stay and discharge disposition only explained 15% of the inter-hospital variation. Researchers called for efforts to identify practices associated with low rates or readmission.
By Nick Paul Taylor • May 11, 2021 -
Providers supportive of push to overhaul HIPAA, but air serious concerns about data privacy, timing
"We urge OCR to reconsider implementing a massive change to patient privacy laws in the midst of this transition," AMA commented on the Trump-era rule.
By Rebecca Pifer Parduhn • May 10, 2021 -
Pharma erupts as Biden administration backs waiver of vaccine patent rights
The shift in U.S. policy might not undermine future research as the drug industry claims. Easing patent protections, though, isn't likely to translate to an immediate boost in vaccine supply.
By Jonathan Gardner , Ned Pagliarulo • May 7, 2021